BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4991063)

  • 1. Studies for the determination of clinically available criteria of resistance of tubercle bacilli to rifampicin.
    Gomi J; Yanagisawa K; Murohashi T
    Kekkaku; 1970 Oct; 45(10):317-22. PubMed ID: 4991063
    [No Abstract]   [Full Text] [Related]  

  • 2. [Critical concentration for definition of rifampicin resistance of tubercle bacilli].
    Tsukamura M
    Kekkaku; 1972 May; 47(5):113-9. PubMed ID: 4625369
    [No Abstract]   [Full Text] [Related]  

  • 3. Sensitivity to Ethambutol and Rifampicin of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
    Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG
    Ceylon Med J; 1982 Jun; 27(2):75-9. PubMed ID: 6819093
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the problems of resistance to antituberculous drugs. II--1. Clinically applicable criteria of drug-resistance to rifampicin].
    Baba H
    Kekkaku; 1994 Jun; 69(6):387-96. PubMed ID: 8041057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987.
    Jalleh RD; Kuppusamy I; Soshila R; Aziah AM; Faridza MY
    Med J Malaysia; 1993 Jun; 48(2):113-6. PubMed ID: 8350784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical studies on the bacterial resistance to rifampicin].
    Sakurai H; Inoue I; Yamagami K
    Kekkaku; 1972 Dec; 47(12):475-9. PubMed ID: 4631478
    [No Abstract]   [Full Text] [Related]  

  • 7. [An investigation on multiple drug resistance of the rifampin resistant strains of Mycobacterium tuberculosis].
    Kuang T; Jin G; Song P; Li W; Wang Z
    Wei Sheng Wu Xue Bao; 1998 Apr; 38(2):152-4. PubMed ID: 12549378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on thiacetazone resistance of tubercle bacilli. I. Thiacetazone sensitivity of tubercle bacilli isolated from previously untreated tuberculous children].
    Osato T; Tsukagoshi K; Shimizu H
    Kekkaku; 1971 May; 46(3):65-70. PubMed ID: 4101569
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the development of drug-resistant tubercle bacilli in experimental animal tuberculosis].
    Yamanouchi T; Sawai A; Hori M
    Kekkaku; 1973 Jul; 48(7):277-95. PubMed ID: 4200057
    [No Abstract]   [Full Text] [Related]  

  • 10. [The clinical significance of the critical drug concentration of rifampicin. Report 1. Studies on the MIC of rifampicin to tubercle bacilli isolated from the rifampicin untreated patients using 1% Ogawa medium (author's transl)].
    Baba H; Azuma Y
    Kekkaku; 1976 Jan; 51(1):1-5. PubMed ID: 815708
    [No Abstract]   [Full Text] [Related]  

  • 11. [The critical concentration of clinical rifampicin resistance for tubercle bacilli and the acquirement pattern of rifampicin resistance of tubercle bacilli on Kirchner's semi-liquid agar media].
    Tamura M; Yamazaki A; Tamura T; Takano S; Yamazaki M
    Kekkaku; 1973 Jun; 48(6):247-53. PubMed ID: 4200023
    [No Abstract]   [Full Text] [Related]  

  • 12. [Percentual content of Rifampicin-resistant mutants in the wild strains of tubercle bacilli isolated from patients untreated with rifampicin].
    Blitek-Golc D; Antosiewicz A; Zduńczyk-Pawelek H
    Gruzlica; 1972 Sep; 40(9):833-9. PubMed ID: 4631233
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies of the criteria of chemoresistance to rifampicin and ethambutol].
    Bogdănescu V; Negulescu E; Ticău S; Vlădescu D
    Ftiziologia; 1973; 22(6):611-21. PubMed ID: 4204427
    [No Abstract]   [Full Text] [Related]  

  • 14. [Resistance of tubercle bacilli to rifampicin in experimental tuberculosis induced in laboratory animals].
    Janowiec M; Wierzejska H
    Gruzlica; 1973 Mar; 41(3):251-7. PubMed ID: 4633122
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative studies on the influence of dimethylsulfoxide (DMSO) on reversion to sensitivity to isonicotinic acid hydrazide (INH) and rifampicin (RMP) in resistant strains of tubercle bacilli.
    Szydłowska T; Pawłowska I
    Arch Immunol Ther Exp (Warsz); 1976; 24(4):575-7. PubMed ID: 826230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acquired resistance of Mycobacterium tuberculosis to rifampicin].
    Fernández Guerrero ML; Posada Dueñas R; Fernández Lazcano F; Padilla Manzuco JM
    Rev Clin Esp; 1978 Sep; 150(6):357-9. PubMed ID: 103148
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug sensitivity of tubercle bacilli to ethambutol and rifampicin determined by the Canetti proportional method].
    Woźniak-Dubla S; Tomaszkiewicz L
    Pneumonol Pol; 1977 Dec; 45(12):785-91. PubMed ID: 414214
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bacteriostatic effect of rifampicin (Rifampin) on Mycobacterium tuberculosis in vitro].
    Woźniak S; Tomaszkiewicz L; Zierski M
    Gruzlica; 1969 Nov; 37(11):983-9. PubMed ID: 4983868
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bactericidal effect of rifampicin on resting tubercle bacilli in vitro (author's transl)].
    Kanai K; Kondo E
    Kekkaku; 1979 Feb; 54(2):89-92. PubMed ID: 108446
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bacteriologic test during rifampicin treatment].
    Ivaldy F
    Rev Tuberc Pneumol (Paris); 1969; 33(6):818-20. PubMed ID: 4989191
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.